Current status: 898 hESC lines, 4286 hiPSC lines, and 119 clinical studies, and 1119 certificates
Monthly statistic from Jul 1, 2023
Posted on July 1, 2023
| total lines | 5184 |
| hESC lines | 898 |
| hiPSC lines | 4286 |
| derivation countries | 46 |
| projects | 273 |
| providers | 822 |
| clinical studies | 119 |
| subclones | 2173 |
| certificates | 1119 |
| cell line certificates | 980 |
| project certificates | 139 |